Compare BMY & SNPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BMY | SNPS |
|---|---|---|
| Founded | 1887 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 127.0B | 90.9B |
| IPO Year | 2006 | 1994 |
| Metric | BMY | SNPS |
|---|---|---|
| Price | $60.67 | $433.75 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 28 | 25 |
| Target Price | $65.25 | ★ $589.55 |
| AVG Volume (30 Days) | ★ 9.2M | 1.7M |
| Earning Date | 10-29-2026 | 12-08-2026 |
| Dividend Yield | ★ 4.11% | N/A |
| EPS Growth | ★ 178.46 | N/A |
| EPS | ★ 3.98 | 3.27 |
| Revenue | ★ $48,194,000,000.00 | $5,081,542,000.00 |
| Revenue This Year | $4.23 | $37.81 |
| Revenue Next Year | N/A | $13.18 |
| P/E Ratio | ★ $15.42 | $133.21 |
| Revenue Growth | N/A | ★ 20.87 |
| 52 Week Low | $45.27 | $362.55 |
| 52 Week High | $68.64 | $539.48 |
| Indicator | BMY | SNPS |
|---|---|---|
| Relative Strength Index (RSI) | 43.05 | 43.03 |
| Support Level | $59.94 | $403.46 |
| Resistance Level | $60.93 | $444.66 |
| Average True Range (ATR) | 1.67 | 15.53 |
| MACD | -0.15 | -3.66 |
| Stochastic Oscillator | 1.05 | 17.31 |
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Synopsys is a provider of electronic design automation software and intellectual property products. EDA software automates and aids in the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Synopsys' comprehensive portfolio is benefiting from a convergence of semiconductor companies moving up the stack of technologies toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.